Literature DB >> 12526691

Tat-conjugated synthetic macromolecules facilitate cytoplasmic drug delivery to human ovarian carcinoma cells.

Aparna Nori1, Keith D Jensen, Monica Tijerina, Pavla Kopecková, Jindrich Kopecek.   

Abstract

We have synthesized N-(2-hydroxypropyl)methacrylamide (HPMA) copolymer-cell penetrating peptide Tat conjugates and evaluated their subcellular distribution in A2780 human ovarian carcinoma cells by confocal fluorescence microscopy and subcellular fractionation. Our data indicate the transport of these conjugates by a single Tat molecule to both the cytoplasm and nucleus via a nonendocytotic and concentration independent process. The uptake was observed to occur within 3 min, as confirmed by live cell microscopy. In contrast, HPMA copolymers lacking the Tat peptide were internalized solely by endocytosis. For the first time, Tat-mediated cytoplasmic delivery of a polymer bound anticancer drug, doxorubicin, was also demonstrated. These findings establish the feasibility of overcoming major cellular and subcellular obstacles to intracellular macromolecular delivery and hold great promise for the development of polymer-based systems for the cytoplasmic delivery of therapeutic molecules.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12526691     DOI: 10.1021/bc0255900

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  25 in total

1.  Peptide-linked molecular beacons for efficient delivery and rapid mRNA detection in living cells.

Authors:  Nitin Nitin; Philip J Santangelo; Gloria Kim; Shuming Nie; Gang Bao
Journal:  Nucleic Acids Res       Date:  2004-04-14       Impact factor: 16.971

Review 2.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

Review 3.  Nanocarriers' entry into the cell: relevance to drug delivery.

Authors:  Hervé Hillaireau; Patrick Couvreur
Journal:  Cell Mol Life Sci       Date:  2009-06-05       Impact factor: 9.261

4.  Signal sequences for targeting of gene therapy products to subcellular compartments: the role of CRM1 in nucleocytoplasmic shuttling of the protein switch.

Authors:  Mudit Kakar; Amy B Cadwallader; James R Davis; Carol S Lim
Journal:  Pharm Res       Date:  2007-06-13       Impact factor: 4.200

Review 5.  Antimicrobial peptides with cell-penetrating peptide properties and vice versa.

Authors:  Katrin Splith; Ines Neundorf
Journal:  Eur Biophys J       Date:  2011-02-19       Impact factor: 1.733

6.  Synthesis and in vitro inhibition properties of oligonucleotide conjugates carrying amphipathic proline-rich peptide derivatives of the sweet arrow peptide (SAP).

Authors:  Santiago Grijalvo; Ramon Eritja
Journal:  Mol Divers       Date:  2012-03-06       Impact factor: 2.943

Review 7.  Controlling subcellular delivery to optimize therapeutic effect.

Authors:  Mohanad Mossalam; Andrew S Dixon; Carol S Lim
Journal:  Ther Deliv       Date:  2010-07

Review 8.  Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors:  Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal:  Oligonucleotides       Date:  2007

9.  Cell entry of arginine-rich peptides is independent of endocytosis.

Authors:  Gohar Ter-Avetisyan; Gisela Tünnemann; Danny Nowak; Matthias Nitschke; Andreas Herrmann; Marek Drab; M Cristina Cardoso
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

Review 10.  Protein- and peptide-modified synthetic polymeric biomaterials.

Authors:  Ohm D Krishna; Kristi L Kiick
Journal:  Biopolymers       Date:  2010       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.